Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 24, 1659-1665, October 1, 1964]
© 1964 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ulfohn, A.
Right arrow Articles by Seligman, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ulfohn, A.
Right arrow Articles by Seligman, A. M.

The Duration of the Myelotoxic Effects of Circulating Alkylating Agents

Adolph Ulfohn, Stanley P. Kramer, Howard Dorfman, Benjamin Witten, Charles Williamson, Samuel Sass, Jacob I. Miller and Arnold M. Seligman

( Departments of Surgery, Sinai Hospital of Baltimore, Inc., and The Johns Hopkins University, School of Medicine, Baltimore, Maryland; and The Chemical Research Division, U. S. Army Chemical Research and Development Laboratories, Edgewood Arsenal, Maryland)

A technic has been devised to measure the active drug in circulating blood at various intervals after the intravenous injection of alkylating agents. The circulation to one hind leg (the protected leg) of a rabbit is blocked by tourniquet for varying periods of time during and after intravenous injection of an alkylating agent. After sacrifice of the rabbit (in 4 days) the bone marrows of the protected and unprotected legs are compared for changes in cellularity.

All the sulfur mustards tested, with the possible exception of S-170, disappeared rapidly from the circulation irrespective of their in vitro half-lives. Certain other alkylating agents such as bis-(1-aziridinyl)morpholinophosphine oxide and Sarcolysin did not follow this pattern. In these instances a toxic level was maintained in circulating blood for longer periods of time. The present study indicated that this technic may be useful for comparing agents with relatively long half-lives but not for comparison of agents with very short half-lives. It is probably more useful for predicting clinical behavior than is the in vitro half-life.

Received 5/21/64.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1964 by the American Association for Cancer Research.